Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.040 (3.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $25.52 million as of December 5, 2025. Its market cap has decreased by -61.73% in one year.
Market Cap
25.52M
Enterprise Value
-42.29M
1-Year Change
-61.73%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $25.52M, a decrease of -92.83%. That is a compound annual growth rate of -79.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 24.62M | -61.92% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |